A novel [Mn₂(μ-(C₆H₅)₂CHCOO)₂(bipy)₄](bipy)(ClO₄)₂ complex loaded solid lipid nanoparticles: synthesis, characterization and in vitro cytotoxicity on MCF-7 breast cancer cells

References

• Ali I. Nano anti-cancer drugs: Pros and cons and future perspectives. Curr Cancer Drug Targets, 2011;11(2):131–4.
   PubMed Web of Science ®Google Scholar
• Ali I, Rahis-Uddin Salim K, Rather MA, Wani WA Haque A. Advances in nano drugs for cancer chemotherapy. Curr Cancer Drug Targets, 2011;11(2):135–46.
   PubMed Web of Science ®Google Scholar
• Ali I, Wani WA, Saleem K, Haque A. Platinum compounds: A hope for future cancer chemotherapy. Anticancer Agents Med Chem, 2013a;13(2):296–306.
   PubMed Web of Science ®Google Scholar
• Ali I, Wani WA, Saleem K, Wesselinova D. Syntheses, DNA binding and anticancer profiles of L-glutamic acid ligand and its Copper(II) and Ruthenium(III) complexes. Med Chem, 2013b;9(1):11–21.
   PubMed Web of Science ®Google Scholar
• Ali I, Lone MN, Al-Othman ZA, Al-Warthan A, Sanagi MM. Heterocyclic scaffolds: Centrality in anticancer drug development. Curr Drug Targets, 2015;16(7):711–34.
   PubMed Web of Science ®Google Scholar
• Ansari KI, Grant JD, Kasiri S, Woldemariam G, Shrestha B, Mandal SS. Manganese(III)-salens induce tumor selective apoptosis in human cells. J Inorg Biochem, 2009;103(5):818–26.
   PubMed Web of Science ®Google Scholar
• Banu KS, Chattopadhyay T, Banerjee A, Mukherjee M, Bhattacharya S, Patra GK, Zangrando E, Das D. Mono- and dinuclear manganese(III) complexes showing efficient catechol oxidase activity: Syntheses, characterization and spectroscopic studies. Dalton Trans, 2009;40:8755–64.
   PubMed Web of Science ®Google Scholar
• Bhaskar K, Anbu J, Ravichandiran V, Venkateswarlu V, Rao YM. Lipid nanoparticles for transdermal delivery of flurbiprofen: Formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis, 2009;8(6):6–15.
   PubMed Web of Science ®Google Scholar
• Bruijnincx PCA, Sadler PJ. New trends for metal complexes with anticancer activity. Curr Opin Chem Biol, 2008;12:197–206.
   PubMed Web of Science ®Google Scholar
• Cańada-Vilalta C, Huffman JC, Streib WE, Davidson ER, Christou G. Use of the dicarboxylate ligand m-phenylenedipropionate for the synthesis of new Mn/O clusters. Synthesis, characterisation and magnetic properties. Polyhedron, 2001;20:1375.
   Web of Science ®Google Scholar
• Chen QY, Zhou DF, Huang J, Guo WJ, Gao J. Synthesis, anticancer activities, interaction with DNA and mitochondria of manganese complexes. J Inorg Biochem, 2010;104(11):1141–9.
   PubMed Web of Science ®Google Scholar
• Dash SK, Chattopadhyay S, Ghosh T, Tripathy S, Das S, Das D, Roy S. Antileukemic efficacy of monomeric manganese-based metal complex on KG-1A and K562 cell lines. ISRN Oncol, 2013;2013:1–10.
   Google Scholar
• Day JD. Catalase and glutathione peroxidase mimics. Biochem Pharmacol, 2009;77(3):285–96.
   PubMed Web of Science ®Google Scholar
• Desoıze B. Metals and metal compounds in cancer treatment. Antıcancer Res, 2004;24(3a):1529–44.
   PubMed Web of Science ®Google Scholar
• Dikmen G, Genç L, Güney G. Advantage and disadvantage in drug delivery systems. J Mat Sci Eng, 2011;5:468–72.
   Google Scholar
• Dikmen G, Güney G, Genç L. Characterization of solid lipid nanoparticles containing caffeic acid and determination of its effects on MCF-7 cells. Recent Pat Anticancer Drug Discov, 2015;10(2):224–32.
   PubMed Web of Science ®Google Scholar
• Fenández G, Corbella M, Alfonso M, Stoeckli-Evans H, Castro I. A comparative XAS and X-ray diffraction study of new binuclear Mn(III) complexes with catalase activity. Indirect effect of the counteranion on magnetic properties. Inorg Chem, 2004;43(21):6684–98.
   Google Scholar
• Garud A, Singh D, Garud N. Solid lipid nanoparticles (SLN): Method, characterization and applications. Int Curr Pharm J, 2012;1(11):384–93.
   Google Scholar
• Genc L, Kutlu HM, Güney G. Vitamin B12 loaded solid lipid nanoparticles as a drug carrier in cancer therapy. Pharm Dev Technol, 2015;20(3):337–44.
   PubMed Web of Science ®Google Scholar
• Genc L. Preparation and characterization of nocodazoleloaded solid lipid nanoparticles. Pharm Dev Technol, 2014;19(6): 671–6.
   PubMed Web of Science ®Google Scholar
• Genç L, Dikmen G, Güney G. Formultion of nano drug delivery systems. J Mat Sci Eng, 2011;1:132–7.
   Google Scholar
• Ghosh K, Tyagi N, Kumar P, Singh UP, Goel N. Stabilization of Mn(II) and Mn(III) in mononuclear complexes derived from tridentate ligands with N2O donors: Synthesis, crystal structure, superoxide dismutase activity and DNA interaction studies. J Inorg Biochem, 2010;104(1):9–18.
   PubMed Web of Science ®Google Scholar
• Ghosh RD, Banerjee K, Das S, Ganguly A, Chakraborty P, Sarkar A, Chatterjee M, Choudhuri SK. A novel manganese complex, Mn-(II) N-(2-hydroxy acetophenone) glycinate overcomes multidrug-resistance in cancer. Eur J Pharm Sci, 2013;49(4):737–47.
   PubMed Web of Science ®Google Scholar
• Güney Eskiler G, Dikmen G, Genç L. 2015. Nano-based drug delivery system. In: Jitendra N ed. Nano based drug delivery. Zagreb, Croatia: IAPC Publishing, pp. 89–133.
   Google Scholar
• Güney G, Genç L, Dikmen G. Use of nanocarrier systems in cancer therapy. J Mat Sci Eng, 2011;5:577–82.
   Google Scholar
• Güney G, Kutlu HM, Genç L. Preparation and characterization of ascorbic acid loaded solid lipid nanoparticles and investigation of their apoptotic effects. Colloids Surf B Biointerfaces, 2014;121:270–80.
   PubMed Web of Science ®Google Scholar
• Hannon MJ. Metal-based anticancer drugs: From a past anchored in platinum chemistry to a post-genomic future of diverse chemistry and biology. Pure Appl Chem, 2007;79(12):2243–61.
   Web of Science ®Google Scholar
• Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems – A review (Part 1). Trop J Pharmaceut Res, 2013;12(2):255–64.
   Web of Science ®Google Scholar
• Jungwirth U, Kowol CR, Keppler BK, Hartinger CG, Berger W, Heffeter P. Anticancer activity of metal complexes: Involvement of redox processes. Antioxid Redox Signal, 2011;15(4):1085–127.
   PubMed Web of Science ®Google Scholar
• Kutlu HM, Genc L, Güney G. The impact of caffeic acid loaded solid lipid nanoparticles on cancer treatment. Pharm Dev Technol, 2013;9(6):698–703.
   Google Scholar
• Liu J, Guo W, Li J, Li X, Geng J, Chen Q, Gao J. Tumor-targeting novel manganese complex induces ROS-mediated apoptotic and autophagic cancer cell death. Int J Mol Med, 2015;35(3):607–16.
   PubMed Web of Science ®Google Scholar
• Madureira AR, Campos DA, Fonte P, Nunes S, Reis F, Gomes AM, Sarmento B, Pintado MM. Characterization of solid lipid nanoparticles produced with carnauba wax for rosmarinic acid oral delivery. RDC Adv, 2015;5(29):22665–73.
   Google Scholar
• Mathur S, Satrawala Y, Rajput MS, Kumar P, Shrivastava P, Vishvkarma A. Solid lipid nanoparticles in cancer therapy. Int J Drug Del, 2010;2(3):192–199.
   Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Del Rev, 2001;47(2–3):165–9.
   PubMed Web of Science ®Google Scholar
• Miao J, Du Y-Z, Yuan H, Zhang X, Hu F-Q. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells. Colloids Surfaces B Biointerfaces, 2013;110:74–80.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: A modern formulation approach in drug delivery system. Indian J Pharm Sci, 2009;71(4):349–58.
   PubMed Web of Science ®Google Scholar
• Muller RH, Dingler A, Schneppe T. 2000a. Large scale production of solid lipid nanoparticles (SLN™) and nanosuspensions (DissoCubes®). In: Wise D, ed. Handbook of pharmaceutical controlled release technology. 2nd edn. New York: Marcel Dekker, pp. 359–76.
   Google Scholar
• Muller RH, Karsten M, Sven G. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm, 2000b;50(1):161–77.
   PubMed Web of Science ®Google Scholar
• Muller RH, Keck CM. Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol, 2004;113(1–3):151–70.
   PubMed Web of Science ®Google Scholar
• Muller RH, Mehnert W, Souto EB. 2005. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for dermal delivery. In: Bronaugh L, ed. Percutaneous absorption. New York: Marcel Dekker, pp. 719–38.
   Google Scholar
• Harms M, Müller-Goymann CC. Solid lipid nanoparticles for drug delivery. J Drug Del Sci Tech, 2011;21(1):89–99.
   Web of Science ®Google Scholar
• Nallasamy P, Ramaswamy M. Synthesis, spectral characterization, and single crystal X-ray structures of a series of manganese-2,2′-bipyridine complexes derived from substituted aromatic carboxylic acids. Inorg Chim Acta, 2011;365(1):430–8.
   Web of Science ®Google Scholar
• Olbrich C, Müller RH. Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures. Int J Pharm, 1991;180(1):31–9.
   Web of Science ®Google Scholar
• Otto D, de Villiers MM. 2009. Physicochemical principles of nanosized drug delivery systems. In: de Villiers MM, Aramwit P, Kwon GS, eds. Nanotechnology in drug delivery. Berlin: Springer, pp. 3–35.
   Google Scholar
• Rafique S, Idrees M, Nasim A, Akbar H, Athar A. Transition metal complexes as potential therapeutic agents. Biotechnol Mol Biol Rev, 2010;5(2):38–45.
   Google Scholar
• Sheldrick GM. Phase annealing in SHELX-90: Direct methods for larger structures. Acta Cryst, 1990;A46:467–73.
   Web of Science ®Google Scholar
• Sheldrick GM. 1997. SHELXS 97, Program for the solution of crystal structure. Gottingen, Germany: University of Gottingen.
   Google Scholar
• Souto EB, Muller RH. 2007. Lipid nanoparticles (solid lipid nanoparticles and nanostructured lipid carriers) for cosmetic, dermal and transdermal applications. In: Thassu D, Deleers M, Pathak Y, eds. Nanoparticulate drug delivery systems: recent trends and emerging technologies. CRC Press, pp. 213–33.
   Google Scholar
• Souto EB, Doktorovova S. Solid lipid nanoparticle formulations, pharmacokinetic and biopharmaceutical aspects in drug delivery. Methods Enzymol, 2009;464:105–29.
   PubMed Web of Science ®Google Scholar
• Spek AL. 2005. Platon - a multipurpose crystallographic tool utrecht, The Netherlands: Utrecht University.
   Google Scholar
• Subedi RK, Kang KW, Choi H. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci, 2009;37(3–4):508–13.
   PubMed Web of Science ®Google Scholar
• Swami A, Shi J, Gadde S, Votruba AR, Kolishetti N, Farokhzad OC. 2012. Nanoparticles for targeted and temporally controlled drug delivery. In: Svenson S, Prud’homme RK, eds. Multifunctional nanoparticles for drug delivery applications. New York: Springer-Verlag, pp. 2–29.
   Google Scholar
• Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Bannerjee SK. Drug delivery systems: An updated review. Int J Pharm Investig, 2012;2(1):2–11.
   PubMedGoogle Scholar
• Wang R, Hong M, Gao E, Gao M, Luo J, Han L, Cao R. A three-dimensional manganeseII complex exhibiting ferrimagnetic and metamagnetic behaviors. Inorg Chem, 2003;42(18):5486–8.
   PubMed Web of Science ®Google Scholar
• Wani WA, Alothman ZA, Ali I, Saleem K, Hsieh M. Copper(II), nickel(II) and ruthenium(III) complexes of an oxopyrrolidine based heterocyclic ligand as anticancer agents. J Coord Chem, 2014;67(12):2110–30.
   Web of Science ®Google Scholar
• Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H. Nanoparticles as drug delivery systems. Pharmacol Rep, 2012;64(5):1020–37.
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev, 2007;59(6):491–504.
   PubMed Web of Science ®Google Scholar
• Yan YK, Melchart M, Habtemariam A, Sadler PJ. Organometallic chemistry, biology and medicine: Ruthenium arene anticancer complexes. Chem Commun, 2005;38:4764–76.
   PubMed Web of Science ®Google Scholar
• Yao L, Chen Q, Xu X, Li Z, Wang X. Interaction of manganese(II) complex with apotransferrin and the apotransferrin enhanced anticancer activities. Spectrochim Acta A Mol Biomol Spectrosc, 2013;105:207–12.
   PubMed Web of Science ®Google Scholar
• Yassin AE, Albekairy AM, Alkatheri A, Sharma RK. Anticancer-loaded solid lipid nanoparticles: High potential advancement in chemotherapy. Dig J Nanomater Biostruct, 2013;8(2):905–16.
   Web of Science ®Google Scholar
• Zhou DF, Chen QY, Qi Y, Fu HJ, Li Z, Zhao KD, Gao J. Anticancer activity, attenuation on the absorption of calcium in mitochondria, and catalase activity for manganese complexes of N-substituted Di(picolyl)amine. Inorg Chem, 2011;50:6929–37.
   PubMed Web of Science ®Google Scholar